Watchlist

Watchlist
Apollo Endosurgery, Inc. (APEN)
Apollo Endosurgery, Inc. (APEN)
Apollo Endosurgery to Feature Industry-Advancing Endoscopic Procedure Portfolio During Digestive Disease Week® 2018 Conference
Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today its participation during Digestive Disease Week 2018 (DDW). DDW will be held June 2-5, 2018 at the …
Apollo Endosurgery Announces Spanish Study of ESG in NASH Patients
Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the enrollment of the first patient in a multicenter, randomized, controlled, double-blind study of the efficacy an…
Apollo Endosurgery Establishes European Registry for Bariatric Flexible Endoscopic Suturing Procedures
Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the establishment of a multicenter, longitudinal, data repository for Endoscopic Sleeve Gastroplasty (ESG&#…
Apollo Endosurgery misses by $0.07, misses on revenue
Apollo Endosurgery (NASDAQ: APEN ): Q1 EPS of -$0.47 misses by $0.07 . More news on: Apollo Endosurgery, Earnings news and commentary, Healthcare stocks news, , Read more …
Apollo Endosurgery, Inc. Reports First Quarter 2018 Results
Total Endo-bariatric Product Sales Increased 40% in the First Quarter Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a leader in less invasive medical devices for bariatric and gastrointestinal proce…
Apollo Endosurgery, Inc. to Report First Quarter Results on May 3, 2018
Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that it plans to release its financial results for the first quarter ended March 31, 2018 on Thursday, May 3, 2018,…
Apollo Endosurgery Announces Approval of the New 12-month Weight Loss Balloon - ORBERA365(TM) - in the Kingdom of Saudi Arabia
Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Saudi Food and Drug Authority (SFDA) has approved the ORBERA365 Managed Weight Loss System and has…
Premarket analyst action - healthcare
Celgene (NASDAQ: CELG ) resumed with Equal Weight rating and $93 (4% upside) price target at Morgan Stanley. More news on: Celgene Corporation, Corcept Therapeutics Incorporated, Endocyte, Inc., Healthcare stocks news, Stocks on the move, , Read more …
Apollo Endosurgery Announces Conclusion of LAP-BAND® Low BMI Post-Approval Study
Apollo Endosurgery, Inc. (Apollo) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the FDA has approved the termination of the LAP-BAND Lower Body Mass Index (BMI) Post-approval study (&#…
Apollo Endosurgery, Inc. to Participate at the 30th Annual ROTH Conference
Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today that Company management is scheduled to present at the 30 th Annual ROTH Conference being held March 11-14, 2018 at the Ritz-Carlton La…
Apollo Endosurgery, Inc. (APEN)